You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2024

Litigation Details for Salix Pharmaceuticals Ltd. v. Sun Pharmaceuticals Industries Ltd. (D. Del. 2019)


✉ Email this page to a colleague

« Back to Dashboard


Salix Pharmaceuticals Ltd. v. Sun Pharmaceuticals Industries Ltd. (D. Del. 2019)

Docket ⤷  Sign Up Date Filed 2019-04-24
Court District Court, D. Delaware Date Terminated 2020-09-25
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand Both Referred To
Parties SALIX PHARMACEUTICALS, INC.
Patents 10,314,828; 10,335,397; 10,456,384; 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275; 7,928,115; 8,158,644; 8,158,781; 8,193,196; 8,309,569; 8,518,949; 8,642,573; 8,741,904; 8,829,017; 8,835,452; 8,853,231; 8,946,252; 8,969,398; 9,271,968; 9,421,195; 9,629,828
Attorneys Elizabeth E. Grden
Firms Morris, Nichols, Arsht & Tunnell LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Salix Pharmaceuticals Ltd. v. Sun Pharmaceuticals Industries Ltd.
The small molecule drug covered by the patents cited in this case is ⤷  Sign Up .

Details for Salix Pharmaceuticals Ltd. v. Sun Pharmaceuticals Industries Ltd. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-03-26 1 Complaint United States Patent Nos. 7,045,620 (the “’620 patent”); 7,612,199 (the “’199 patent”); 7,902,206 (the…infringed one or more claims of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 8,158,644…infringe one or more claims of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 8,158,… C. A judgment that United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 8,158,644…to the expiration date of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 8,158,644 External link to document
2021-08-03 118 the Invalidity of U.S. Patent Nos. 8,642,573; 8,969,398; 9,421,195; 10,335,397; and 10,709,694 4. Opening…Bergstrom, Ph.D. Regarding the Invalidity of U.S. Patent No. 7,906,542 2. Opening Expert of Michael J. Zaworotko…Zaworotko, Ph.D. Regarding the Invalidity of U.S. Patent Nos. 7,045,620; 7,612,199; 7,902,206; and 7,906,542… 25 September 2020 1:19-cv-00734 835 Patent - Abbreviated New Drug Application(ANDA) Both External link to document
2021-10-19 138 Ph.D. Regarding the Invalidity of U.S. Patent Nos. 7,045,620; 7,612,199; 7,902,206; and 7,906,542 (3)…Bergstrom, Ph.D. Regarding the Invalidity of U.S. Patent No. 7,906,542 (7) Responsive Expert Report of Richard…Regarding Noninfringement of Claims 9 and 10 of U.S. Patent No. 7,906,542 filed by Norwich Pharmaceuticals … 25 September 2020 1:19-cv-00734 835 Patent - Abbreviated New Drug Application(ANDA) Both External link to document
2020-03-26 4 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,045,620 ;7,612,199 ;7,902,206… 25 September 2020 1:19-cv-00734 835 Patent - Abbreviated New Drug Application(ANDA) Both External link to document
2020-11-12 60 Appendix the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 7,045,620; 7,612,199; 7,902,… 25 September 2020 1:19-cv-00734 835 Patent - Abbreviated New Drug Application(ANDA) Both External link to document
2020-09-25 70 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,045,620; 7,612,199; 7,902,206… 25 September 2020 1:19-cv-00734 835 Patent - Abbreviated New Drug Application(ANDA) Both External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.